Australia markets closed

INVO Bioscience, Inc. (INVO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9800-0.0001 (-0.01%)
At close: 04:00PM EDT
0.9801 +0.00 (+0.01%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,021
3,021
822.196
4,160
1,037
Cost of revenue
1,934
1,934
850.77
145.052
88.76
Gross profit
1,086
1,086
-28.574
4,015
948.526
Operating expenses
Research development
165.945
165.945
544.043
216.43
398.426
Selling general and administrative
7,486
7,486
9,977
9,015
6,065
Total operating expenses
7,853
7,853
10,598
9,232
6,463
Operating income or loss
-6,767
-6,767
-10,626
-5,217
-5,515
Interest expense
925.909
925.909
59.445
1,265
2,837
Total other income/expenses net
-313.762
-313.762
-204.021
-171.95
-
Income before tax
-8,007
-8,007
-10,890
-6,650
-8,347
Income tax expense
27.786
27.786
2.872
4.764
0.036
Income from continuing operations
-8,035
-8,035
-10,893
-6,655
-8,347
Net income
-8,035
-8,035
-10,893
-6,655
-8,347
Net income available to common shareholders
-8,035
-8,035
-10,893
-6,655
-8,347
Basic EPS
-10.34
-
-17.97
-12.60
-30.40
Diluted EPS
-10.34
-
-17.97
-12.60
-30.40
Basic average shares
938.199
-
606.13
531.62
274.486
Diluted average shares
938.199
-
606.13
531.62
274.486